Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 4
Review
Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,944 | Dovepress* | 5,944+ | 2,331 | 8,275 | |
Totals | 5,944 | 2,331 | 8,275 | ||
*Since 8 August 2008 +Since July 2016 |
View citations on Google Scholar